Extramedullary tissue infiltrates of
acute myeloid leukemia are rare and often difficult to recognize in routine
paraffin-embedded tissue sections. Since appropriate
therapy for these
tumors depends on their precise identification, we have studied a series of tissues infiltrated with primitive myeloid cells using monoclonal and polyclonal
antibodies capable of labeling cells of the myeloid/monocytic system in
paraffin-embedded tissue sections. The current retrospective study involved tissues from 15 patients (eight men and seven women) with a mean age of 51 years (range, 23-77). A diagnosis of extramedullary myeloid cell
tumors had been made on the basis of routine histology,
chloroacetate esterase cytochemical
stain, and--in some cases--electron microscopy.
Paraffin-embedded tissue sections were cut and stained employing the
alkaline phosphatase antialkaline
phosphatase (APAAP) immunocytochemical procedure with
monoclonal antibodies against
leukocyte-common antigen (PD7/26-2B11), restricted components of the
leukocyte-common antigen (UCHL1, 4KB5), granulocytes (Mac-387, Leu-M1), leukocytes (MT1, MT2, LN1, LN2),
HLA-DR (LN3), and
elastase (NP57), as well as polyclonal
antibodies against
lactoferrin,
lysozyme, alpha-1-antitrypsin, and alpha-1-antichymotrypsin. Results indicate that
antibodies against Mac-387,
elastase, and
lysozyme are most useful in the recognition of neoplastic myeloid cells. We conclude that tissues containing granulocytic
tumors can be identified in
paraffin-embedded tissue sections using a panel of
antibodies and the APAAP procedure.